The use of Stem Cells for COVID-19 Therapy
There are now numerous uses and investigations for experimental stem cell therapy in severely ill COVID-19 patients, particularly MSC therapy. MSCs are produced from the mesoderm and ectoderm during the early stages of embryonic development, and they have gotten a lot of press because of their multidirectional differentiation capability, immunomodulatory capabilities, and lack of ethical issues. stem cell treatment offers extensive clinical application possibilities and far-reaching relevance thanks to the ongoing exploration of stem cell clinical research and data mining.
Related Conference of The use of Stem Cells for COVID-19 Therapy
September 24-25, 2026
19th World Congress on Advances in Stem Cell Research and Regenerative Medicine
Paris, France
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan

